145 related articles for article (PubMed ID: 15846253)
21. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
Lindstedt G
Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
[No Abstract] [Full Text] [Related]
22. BNP in the diagnosis and risk stratification of heart failure.
Moe GW
Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
[TBL] [Abstract][Full Text] [Related]
23. [BNP or NT-proBNP should be analyzed in suspected heart failure. Guidelines for analysis and interpretation].
Jernberg T; Boman K; James S; Lindahl B; Stridsberg M; Swedberg K; Venge P
Lakartidningen; 2006 Apr 26-May 2; 103(17):1289-92, 1295. PubMed ID: 16708856
[No Abstract] [Full Text] [Related]
24. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
Miller WL; Burnett JC; Hartman KA; Henle MP; Burritt MF; Jaffe AS
Am J Cardiol; 2005 Sep; 96(6):837-41. PubMed ID: 16169373
[TBL] [Abstract][Full Text] [Related]
25. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
[TBL] [Abstract][Full Text] [Related]
26. Amino-terminal pro-brain natriuretic peptide to diagnose congestive heart failure in patients with impaired kidney function.
Lamb EJ; Vickery S; Price CP
J Am Coll Cardiol; 2006 Sep; 48(5):1060-1; author reply 1061. PubMed ID: 16949506
[No Abstract] [Full Text] [Related]
27. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
Glick A; Michowitz Y; Keren G; George J
Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
[TBL] [Abstract][Full Text] [Related]
28. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
[TBL] [Abstract][Full Text] [Related]
29. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
[TBL] [Abstract][Full Text] [Related]
30. Brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide show a different profile in response to acute decompensated heart failure treatment.
Di Somma S; Magrini L; Tabacco F; Marino R; Talucci V; Marrocco F; Cardelli P; Ferri E; Pittoni V
Congest Heart Fail; 2008; 14(5):245-50. PubMed ID: 18983287
[TBL] [Abstract][Full Text] [Related]
31. In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts.
Rudiger A; Fischler M; Harpes P; Gasser S; Hornemann T; von Eckardstein A; Maggiorini M
Int J Cardiol; 2008 May; 126(1):28-31. PubMed ID: 17477984
[TBL] [Abstract][Full Text] [Related]
32. Heart failure and B-type natriuretic protein.
Hoyne J
Clin Lab Sci; 2009; 22(4):233-9. PubMed ID: 19967919
[No Abstract] [Full Text] [Related]
33. Congenital heart disease, exercise capacity and B-type natriuretic peptide.
Carvalho VO
Cardiol J; 2009; 16(5):489; author reply 490. PubMed ID: 19753535
[No Abstract] [Full Text] [Related]
34. Natriuretic peptides and heart failure.
McLachlan CS; Yu H; Mossop P
CMAJ; 2007 Feb; 176(5):659. PubMed ID: 17325337
[No Abstract] [Full Text] [Related]
35. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure.
Tsutamoto T; Wada A; Sakai H; Ishikawa C; Tanaka T; Hayashi M; Fujii M; Yamamoto T; Dohke T; Ohnishi M; Takashima H; Kinoshita M; Horie M
J Am Coll Cardiol; 2006 Feb; 47(3):582-6. PubMed ID: 16458140
[TBL] [Abstract][Full Text] [Related]
36. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure.
Ralli S; Horwich TB; Fonarow GC
Am Heart J; 2005 Dec; 150(6):1220-7. PubMed ID: 16338262
[TBL] [Abstract][Full Text] [Related]
37. B-type natriuretic peptides: applications for heart failure management in 2005.
Troughton RW; Richards M
Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104
[No Abstract] [Full Text] [Related]
38. Brain natriuretic peptide in heart failure.
Aronow WS
J Am Geriatr Soc; 2006 Feb; 54(2):368-9; author reply 369. PubMed ID: 16460396
[No Abstract] [Full Text] [Related]
39. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
[TBL] [Abstract][Full Text] [Related]
40. BNP or echocardiography for monitoring heart failure?
Sanderson JE
Eur Heart J; 2004 Oct; 25(20):1763-4. PubMed ID: 15474688
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
